-
CFTC Whistleblower Award for Benchmark Rate Manipulation by Global Banks10/21/2021
CFTC Whistleblower Program award of nearly $200 million in connection with recoveries from global banks that manipulated benchmark rates.
-
Sandell Hedge Fund Tax Whistleblower Settlement
State of NY ex rel. Tooley, LLC v. Sandell, et al., No. 101494/2018. Whistleblower client received award of 21% of $105 million recovery.
-
FPR Specialty Pharmacy
United States ex rel. Doe v. FPR Specialty Pharmacy LLC, No. 16-cv-5204 (SDNY). Whistleblower client received 21% of $426,000 ability to pay settlement
-
Moody’s Corporation Whistleblower Settlement
Anonymous v. Anonymous, No. 103997/2012 (N.Y. Sup. Ct. 2019). Whistleblower client received award of 30% of $8.5 million recovery.
-
JPMorgan Chase Escheatment
New York ex rel. Raw Data Analytics v. JPMorgan Chase & Co., No. 100271/2015 (N.Y. Sup. Ct.). Defeated defendants' summary judgment motion, and case continues.
-
Spa Castle Whistleblower Settlement
State of New York ex rel. Choe v. Spa Castle, Inc., No. 101243/2014 (N.Y. Sup. Ct. 2018). Whistleblower client received award of 23% of $2.5 million recovery.
-
Winds Enterprises Whistleblower Settlement
U.S. ex rel. Dickhudt v. Winds Enterprises, No. 13-cv-01142 (W.D. Wa.). Whistleblower client received award of 20% of $1.5 million settlement.
-
Noble Jewelry Whistleblower Settlement
U.S. ex rel. Karlin v. Noble Jewelry Co., No. 08-cv-07826 (S.D.N.Y.). Whistleblower client received award of 19% of $3.85 million settlement.
-
Multi-Defendant Prescription Drug Pricing Settlement
In re Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456 (D. Mass.); City of New York, et al. v. Abbott Laboratories, et al., No. 01-cv-12257 (D. Mass). Represented New York City in False Claims Act case against several prescription drug manufacturers for manipulating Average Wholesale Prices of their drugs, settling for $225 million.
Featured Cases